Tech Company Financing Transactions
QuantHealth Funding Round
Qumra Capital, Artofin VC and Bertelsmann Investments participated in a $45 million Series B funding round for QuantHealth. The round was announced by the company on 8/4/2026.
Transaction Overview
Company Name
Announced On
8/4/2026
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to scale enterprise-wide impact, accelerate adoption of simulation-first clinical development, advance its R&D capabilities, grow its workforce, and expand its product portfolio.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
10 Karlibach St, 1st floor
Tel Aviv, Undisclosed
IL
Tel Aviv, Undisclosed
IL
Phone
Undisclosed
Website
Email Address
Overview
Developer of artificial intelligence-based drug development data software designed to conduct patient-centric drug simulations to accelerate and de-risk drug development. The company combines data points from across the clinical and drug development spectrum, provides an AI platform that can predict patient response to both approved and novel therapies, allowing pharma and biotech customers to run variations of their clinical trials to optimize the trial design and increase the probability of trial success, all while enabling discovery of new clinical opportunities and optimization strategies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Orr Inbar
Browse more venture capital transactions:
Prev: 8/4/2026: HappyRobot venture capital transaction
Next: 8/4/2026: Claryx venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs